Tags

Type your tag names separated by a space and hit enter

Accelerating Development of SARS-CoV-2 Vaccines - The Role for Controlled Human Infection Models.
N Engl J Med. 2020 Sep 03; 383(10):e63.NEJM

Authors+Show Affiliations

From the Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore (M.E.D., K.M.N.), the Center for Infectious Diseases Research, Walter Reed Army Institute of Research, Silver Spring (N.L.M.), and the Henry Jackson Foundation, Bethesda (M.R.) - all in Maryland; and the Institute for Global Health and Infectious Diseases, School of Medicine, University of North Carolina, Chapel Hill (M.S.C.).From the Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore (M.E.D., K.M.N.), the Center for Infectious Diseases Research, Walter Reed Army Institute of Research, Silver Spring (N.L.M.), and the Henry Jackson Foundation, Bethesda (M.R.) - all in Maryland; and the Institute for Global Health and Infectious Diseases, School of Medicine, University of North Carolina, Chapel Hill (M.S.C.).From the Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore (M.E.D., K.M.N.), the Center for Infectious Diseases Research, Walter Reed Army Institute of Research, Silver Spring (N.L.M.), and the Henry Jackson Foundation, Bethesda (M.R.) - all in Maryland; and the Institute for Global Health and Infectious Diseases, School of Medicine, University of North Carolina, Chapel Hill (M.S.C.).From the Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore (M.E.D., K.M.N.), the Center for Infectious Diseases Research, Walter Reed Army Institute of Research, Silver Spring (N.L.M.), and the Henry Jackson Foundation, Bethesda (M.R.) - all in Maryland; and the Institute for Global Health and Infectious Diseases, School of Medicine, University of North Carolina, Chapel Hill (M.S.C.).From the Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore (M.E.D., K.M.N.), the Center for Infectious Diseases Research, Walter Reed Army Institute of Research, Silver Spring (N.L.M.), and the Henry Jackson Foundation, Bethesda (M.R.) - all in Maryland; and the Institute for Global Health and Infectious Diseases, School of Medicine, University of North Carolina, Chapel Hill (M.S.C.).

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32610006

Citation

Deming, Meagan E., et al. "Accelerating Development of SARS-CoV-2 Vaccines - the Role for Controlled Human Infection Models." The New England Journal of Medicine, vol. 383, no. 10, 2020, pp. e63.
Deming ME, Michael NL, Robb M, et al. Accelerating Development of SARS-CoV-2 Vaccines - The Role for Controlled Human Infection Models. N Engl J Med. 2020;383(10):e63.
Deming, M. E., Michael, N. L., Robb, M., Cohen, M. S., & Neuzil, K. M. (2020). Accelerating Development of SARS-CoV-2 Vaccines - The Role for Controlled Human Infection Models. The New England Journal of Medicine, 383(10), e63. https://doi.org/10.1056/NEJMp2020076
Deming ME, et al. Accelerating Development of SARS-CoV-2 Vaccines - the Role for Controlled Human Infection Models. N Engl J Med. 2020 Sep 3;383(10):e63. PubMed PMID: 32610006.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Accelerating Development of SARS-CoV-2 Vaccines - The Role for Controlled Human Infection Models. AU - Deming,Meagan E, AU - Michael,Nelson L, AU - Robb,Merlin, AU - Cohen,Myron S, AU - Neuzil,Kathleen M, Y1 - 2020/07/01/ PY - 2020/7/2/pubmed PY - 2020/9/15/medline PY - 2020/7/2/entrez SP - e63 EP - e63 JF - The New England journal of medicine JO - N. Engl. J. Med. VL - 383 IS - 10 SN - 1533-4406 UR - https://www.unboundmedicine.com/medline/citation/32610006/full_citation L2 - https://www.nejm.org/doi/10.1056/NEJMp2020076?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed DB - PRIME DP - Unbound Medicine ER -